AIDS Vaccine A 20-Year Effort

Gard, Carolyn
December 2001
Current Health 2;Dec2001, Vol. 28 Issue 4, p18
Reports the effort of researchers for finding AIDS vaccine in the United States. Definition of AIDS; Description of HIV; Destruction of T cells in the body by HIV.


Related Articles

  • New AIDS Research Center.  // DaKine;Nov2008, Issue 120, p7 

    The article reports that nonprofit company Scripps Research Institute has announced the construction of a $30 million facility dedicated to finding an AIDS vaccine in California in 2008. Research in the new facility is expected to focus on finding a way to induce the production of neutralizing...

  • Understanding Adaptive Clinical Trial Designs. McEnery, Regina // VAX;Nov2010, Vol. 8 Issue 6, p4 

    The article examines the adaptive clinical trial designs which allow investigators to drop AIDS vaccine candidates while the trial is in progress. It mentions that after the positive results from the RV144 trial in Thailand, researchers are calling for more clinical trials and more efficient...

  • Early Results of Therapeutic AIDS Vaccine Show Benefit. Kingman, Sharon // BioWorld Today;11/19/2010, Vol. 21 Issue 225, p1 

    The article reports that a phase II trial of a therapeutic vaccine for HIV in Italy showed encouraging interim results. Barbara Ensoli, director of the National AIDS Centre at the Istituto Superiore di Sanitá, claimed that the interim results indicate that treatment of HIV could be improved....

  • IAVI Opens AIDS Vaccine Laboratory in New York City. Kresge, Kristen Jill // VAX;2008, Vol. 12 Issue 6, p3 

    The article reports on the opening of an AIDS Vaccine Design and Development Laboratory by the International AIDS Vaccine Initiative (IAVI) on November 12, 2009 in New York City. It states that the laboratory is the first research facility in the world committed exclusively to the study and...

  • Despite HIV Vaccine Naysayers, Analyses Confirm 'Modest' Claim. Young, Donna // BioWorld Today;10/21/2009, Vol. 20 Issue 203, p1 

    The article reports on a study of a prime-boost HIV vaccine regimen among Thai patients which showed that there was less of a reduction in HIV infection in subgroups of volunteers than previous results. It states that the combination vaccine regimen decreased infections by 31.2 percent based on...

  • SCIENTIFIC STRIDES. Walsh, Noel // Gay Community News;Apr2007, Issue 208, p25 

    The article focuses on research related to the development of anti-human immunodeficiency virus (HIV) vaccines and microbicides for the prevention of Acquired Immune Deficiency Syndrome (AIDS). It is stated that clinical trials of a microbicide gel had to be stopped after researchers found that...

  • Understanding the Importance of Striking a Balance with Vaccination.  // VAX;Jan2015, Vol. 13 Issue 1, p4 

    The article discusses the importance of inducing balance immune response of antibodies and T cells in AIDS vaccines. Topics discussed include the illustration of immune response in a Phase IIb Trial (STEP), a study on balanced immune response conducted by Emory University using rhesus macaques,...

  • Phase I Trial of Novel Prime-boost Regimen Starts in Africa. Bubnoff, Andreas von // VAX;Mar2011, Vol. 9 Issue 2, p3 

    The article reports that the Kenya AIDS Vaccine Initiative in Nairobi, Kenya has begun the phase I clinical trial B002 which will test the safety and immune responses induced by two HIV vaccine candidates administered either sequentially in prime boost regimen or simultaneously.

  • Analysis Identifies Correlates Of AIDS Vaccine Protection. Breindl, Anette // BioWorld Today;4/9/2012, Vol. 23 Issue 68, Special section p1 

    The article focuses on a study by a research team at Duke University which examined factors that influenced the effectiveness of an acquired immune deficiency syndrome (AIDS) vaccine.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics